指标 | 生存者(n = 67) | 非生存者(n = 59) | P值 |
年龄(years) | 58.93 ± 16.91 | 70.85 ± 15.34 | <0.001 |
女/男(n) | 31/36 | 10/49 | <0.001 |
ARDS类型,n (%) |
|
| 0.606 |
轻度 | 21 (31.34%) | 20 (33.90%) |
|
中度 | 42 (62.69%) | 33 (55.93%) |
|
重度 | 4 (5.97%) | 6 (10.17%) |
|
实验室分析 |
|
|
|
AST,U/L | 33 (19~75) | 31 (25~56) | 0.587 |
ALT,U/L | 24 (13~59) | 21 (14~50) | 0.816 |
白蛋白,g/L | 30.5 (28.10~33.50) | 24.8 (22.70~33.10) | <0.001 |
C反应蛋白,ng/ml | 102.15 (49.18~200) | 92.98 (34.31~160.71) | 0.367 |
血小板,×109 | 154 (95~216) | 210 (118~301) | 0.008 |
淋巴细胞,×109 | 0.69 (0.48~0.89) | 0.84 (0.45~1.17) | 0.211 |
降钙素原,ng/ml | 0.59 (0.15~1.74) | 0.72 (0.13~4.28) | 0.615 |
中性粒细胞,×109 | 8.97 (6.14~11.23) | 11.80 (9.71~14.35) | <0.001 |
NAR | 0.28 (0.21~0.37) | 0.45 (0.33~0.61) | <0.001 |
既往史 |
|
|
|
糖尿病,n (%) | 16 (23.9%) | 8 (13.6%) | 0.141 |
高血压,n (%) | 24 (35.8%) | 20 (33.9%) | 0.821 |
COPD,n (%) | 9 (13.4%) | 13 (22.0%) | 0.204 |
评分 |
|
|
|
SOFA | 4 (3~6) | 6 (4~9) | 0.001 |
APACHEII | 15 (12~18) | 18 (16~22) | <0.001 |
治疗方式 |
|
|
|
MV,n (%) | 45 (67.2%) | 51 (86.4%) | 0.011 |
CRRT,n (%) | 12 (17.9%) | 5 (8.5%) | 0.122 |